Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Nash

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Plos One|May 28, 2016
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive GlioblastomaNicholas Brown, Catherine McBain, Stephen Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 25, 2017
Life-course of atopy and allergy-related disease events in tropical sub-Saharan Africa: A birth cohort studySwaib A Lule, Harriet Mpairwe, Margaret Nampijja, et al.
The Lancet. Microbe|December 13, 2025
Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trialGiorgia Gon, Sokvy Ma, Alexander M Aiken, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 12, 2017
Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: Follow-up of a randomized controlled trialBenigna Namara, Stephen Nash, Swaib A Lule, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 7, 2017
Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL studyElizabeth H Phillips, Stephen Nash, Toyin Adedayo, et al.
Emerging Infectious Diseases|August 23, 2021
Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018Peter Holloway, Matthew Gibson, Neeltje van Doremalen, et al.
Nature Communications|January 20, 2025
Camel milk is a neglected source of brucellosis among rural Arab communitiesPeter Holloway, Matthew Gibson, Tanja Holloway, et al.
The Lancet. Microbe|July 25, 2024
MERS-CoV exposure and risk factors for MERS-CoV ELISA seropositivity among members of livestock-owning households in southern Jordan: a population based cross-sectional studyPeter M Holloway, Matthew D Gibson, Tanja T Holloway, et al.
Archives of Sexual Behavior|May 6, 2021
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South AfricaRichard Muhumuza, Andrew Sentoogo Ssemata, Ayoub Kakande, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Plos One|May 28, 2016
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive GlioblastomaNicholas Brown, Catherine McBain, Stephen Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 25, 2017
Life-course of atopy and allergy-related disease events in tropical sub-Saharan Africa: A birth cohort studySwaib A Lule, Harriet Mpairwe, Margaret Nampijja, et al.
The Lancet. Microbe|December 13, 2025
Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trialGiorgia Gon, Sokvy Ma, Alexander M Aiken, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 12, 2017
Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: Follow-up of a randomized controlled trialBenigna Namara, Stephen Nash, Swaib A Lule, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 7, 2017
Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL studyElizabeth H Phillips, Stephen Nash, Toyin Adedayo, et al.
Emerging Infectious Diseases|August 23, 2021
Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018Peter Holloway, Matthew Gibson, Neeltje van Doremalen, et al.
Nature Communications|January 20, 2025
Camel milk is a neglected source of brucellosis among rural Arab communitiesPeter Holloway, Matthew Gibson, Tanja Holloway, et al.
The Lancet. Microbe|July 25, 2024
MERS-CoV exposure and risk factors for MERS-CoV ELISA seropositivity among members of livestock-owning households in southern Jordan: a population based cross-sectional studyPeter M Holloway, Matthew D Gibson, Tanja T Holloway, et al.
Archives of Sexual Behavior|May 6, 2021
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South AfricaRichard Muhumuza, Andrew Sentoogo Ssemata, Ayoub Kakande, et al.
Pageof 7